LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,470 | -19.2% | 2,628 | -2.8% | 0.00% | 0.0% |
| Q2 2023 | $194,958 | -4.4% | 2,704 | -2.5% | 0.00% | 0.0% |
| Q1 2023 | $203,908 | +66.3% | 2,772 | +51.1% | 0.00% | 0.0% |
| Q4 2022 | $122,578 | -39.0% | 1,835 | -21.3% | 0.00% | 0.0% |
| Q3 2022 | $201,000 | -3.4% | 2,331 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $208,000 | -21.2% | 2,331 | -0.7% | 0.00% | 0.0% |
| Q1 2022 | $264,000 | -20.2% | 2,348 | +9.4% | 0.00% | -50.0% |
| Q4 2021 | $331,000 | +40.3% | 2,146 | +26.8% | 0.00% | +100.0% |
| Q3 2021 | $236,000 | +6.3% | 1,692 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $222,000 | -14.0% | 1,692 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $258,000 | +16.7% | 1,692 | -23.7% | 0.00% | +100.0% |
| Q4 2020 | $221,000 | +30.8% | 2,218 | +25.4% | 0.00% | 0.0% |
| Q3 2020 | $169,000 | -14.6% | 1,769 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $198,000 | +92.2% | 1,769 | +25.2% | 0.00% | +100.0% |
| Q1 2020 | $103,000 | -29.9% | 1,413 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $147,000 | +4.3% | 1,413 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $141,000 | -12.4% | 1,413 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $161,000 | -9.6% | 1,413 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $178,000 | -7.8% | 1,413 | -0.4% | 0.00% | 0.0% |
| Q4 2018 | $193,000 | -50.5% | 1,419 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $390,000 | +41.8% | 1,419 | +7.0% | 0.00% | +50.0% |
| Q2 2018 | $275,000 | +51.1% | 1,326 | +20.4% | 0.00% | 0.0% |
| Q1 2018 | $182,000 | +20.5% | 1,101 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $151,000 | +49.5% | 1,101 | +48.4% | 0.00% | 0.0% |
| Q3 2017 | $101,000 | +12.2% | 742 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $90,000 | +32.4% | 742 | +15.2% | 0.00% | 0.0% |
| Q1 2017 | $68,000 | +4.6% | 644 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $65,000 | -1.5% | 644 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $66,000 | -2.9% | 644 | +12.8% | 0.00% | 0.0% |
| Q2 2016 | $68,000 | +11.5% | 571 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $61,000 | -1.6% | 571 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $62,000 | +313.3% | 571 | +219.0% | 0.00% | – |
| Q3 2015 | $15,000 | +50.0% | 179 | +84.5% | 0.00% | – |
| Q2 2015 | $10,000 | +42.9% | 97 | 0.0% | 0.00% | – |
| Q1 2015 | $7,000 | – | 97 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |